Advisor OS LLC Has $477,000 Stock Position in The Cooper Companies, Inc. (NASDAQ:COO)

Advisor OS LLC lessened its holdings in The Cooper Companies, Inc. (NASDAQ:COO) by 45.8% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 5,185 shares of the medical device company’s stock after selling 4,378 shares during the period. Advisor OS LLC’s holdings in Cooper Companies were worth $477,000 at the end of the most recent reporting period.

A number of other large investors have also recently bought and sold shares of COO. Edge Capital Group LLC acquired a new stake in shares of Cooper Companies in the fourth quarter worth about $1,180,000. Y Intercept Hong Kong Ltd bought a new position in shares of Cooper Companies in the 4th quarter valued at approximately $1,985,000. Fjarde AP Fonden Fourth Swedish National Pension Fund raised its stake in shares of Cooper Companies by 44.3% in the 4th quarter. Fjarde AP Fonden Fourth Swedish National Pension Fund now owns 38,120 shares of the medical device company’s stock valued at $3,504,000 after acquiring an additional 11,700 shares in the last quarter. Navellier & Associates Inc. lifted its holdings in Cooper Companies by 30.5% in the 4th quarter. Navellier & Associates Inc. now owns 4,168 shares of the medical device company’s stock worth $383,000 after purchasing an additional 975 shares during the last quarter. Finally, ING Groep NV bought a new stake in Cooper Companies during the fourth quarter worth approximately $555,000. 24.39% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

A number of equities analysts have recently commented on the stock. StockNews.com lowered shares of Cooper Companies from a “buy” rating to a “hold” rating in a research report on Wednesday, December 11th. Needham & Company LLC reiterated a “hold” rating on shares of Cooper Companies in a research note on Friday, December 6th. Citigroup cut their target price on shares of Cooper Companies from $116.00 to $115.00 and set a “buy” rating for the company in a research report on Friday, December 6th. Morgan Stanley lowered their price target on Cooper Companies from $104.00 to $102.00 and set an “equal weight” rating on the stock in a research report on Friday, December 6th. Finally, Wells Fargo & Company lifted their price objective on Cooper Companies from $115.00 to $118.00 and gave the stock an “overweight” rating in a research note on Friday, December 6th. Three investment analysts have rated the stock with a hold rating and nine have given a buy rating to the company. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $117.00.

Cooper Companies Trading Up 0.8 %

Shares of COO opened at $90.97 on Thursday. The stock’s 50-day moving average price is $92.75 and its 200 day moving average price is $99.55. The company has a quick ratio of 1.12, a current ratio of 1.91 and a debt-to-equity ratio of 0.32. The firm has a market capitalization of $18.16 billion, a price-to-earnings ratio of 46.65, a P/E/G ratio of 2.25 and a beta of 1.00. The Cooper Companies, Inc. has a 12-month low of $84.76 and a 12-month high of $112.38.

Cooper Companies (NASDAQ:COO) last released its quarterly earnings data on Thursday, December 5th. The medical device company reported $1.04 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.00 by $0.04. Cooper Companies had a return on equity of 9.38% and a net margin of 10.07%. The business had revenue of $1.02 billion for the quarter, compared to analysts’ expectations of $1.03 billion. During the same period in the previous year, the business posted $0.87 earnings per share. Cooper Companies’s quarterly revenue was up 9.8% on a year-over-year basis. As a group, research analysts predict that The Cooper Companies, Inc. will post 3.98 earnings per share for the current year.

Cooper Companies Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.